IDO2 and breast carcinoma: Similarly, an escalation in lymph node metastases among breast cancer patients correlated with an increase in indoleamine 2,3-dioxygenase (IDO)-expressing CD45+CD33+CD14−CD15− MDSCs within breast cancer tissue (96).